Telemedicine Improves Chronic Disease Access in Indonesia
Researchers from Hamburg University of Technology and collaborators conducted 15 semistructured interviews between October and December 2024 to examine telemedicine adoption in Indonesia. They found the COVID-19 pandemic accelerated virtual consultations, sustaining use for chronic and rare disease follow-ups and delivering cost and travel savings for remote patients. The study identified persistent barriers—limited infrastructure, constrained physical examinations, and physician burnout—calling for regulatory frameworks and digital investment.
Key Points
- 1Identified rapid adoption and normalization of telemedicine in Indonesia after COVID-19, based on 15 interviews.
- 2Highlighted accessibility and cost-efficiency benefits, reducing travel and consultation costs for remote chronic and rare disease patients.
- 3Warned limitations like limited infrastructure, lack of physical exams, and physician burnout, requiring policy and investment.
Scoring Rationale
Moderate actionable country-level findings with peer-reviewed credibility; limited novelty and primarily qualitative, reducing broad applicability.
Sources
Public references used for this report.
Practice interview problems based on real data
1,625 SQL & Python problems across 15 industry datasets — the exact type of data you work with.
Try 250 free problems
